US4000259A
(en)
|
1975-06-16 |
1976-12-28 |
American Home Products Corporation |
Cyclic dodecapeptide analogs of somatostatin and intermediates
|
US4438270A
(en)
|
1977-07-11 |
1984-03-20 |
Merrell Toraude Et Compagnie |
α-Halomethyl derivatives of α-amino acids
|
US4191754A
(en)
|
1979-02-28 |
1980-03-04 |
Merck & Co., Inc. |
Bicyclic somatostatin analogs
|
US4270537A
(en)
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
AU550730B2
(en)
|
1982-03-09 |
1986-04-10 |
Commonwealth Of Australia, The |
Automated metal detection
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
US4730006A
(en)
|
1986-01-27 |
1988-03-08 |
Merrell Dow Pharmaceuticals Inc. |
Derivatives of 2,6-diamino-3-haloheptanedioic acid
|
CA1283827C
(en)
|
1986-12-18 |
1991-05-07 |
Giorgio Cirelli |
Appliance for injection of liquid formulations
|
GB8704027D0
(en)
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
AU3439589A
(en)
|
1988-03-24 |
1989-10-16 |
Terrapin Diagnostics, Inc. |
Molecular sticks for controlling protein conformation
|
US5094951A
(en)
|
1988-06-21 |
1992-03-10 |
Chiron Corporation |
Production of glucose oxidase in recombinant systems
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
US5384309A
(en)
*
|
1989-07-17 |
1995-01-24 |
Genentech, Inc. |
Cyclized peptides and their use as platelet aggregation inhibitors
|
US5120859A
(en)
|
1989-09-22 |
1992-06-09 |
Genentech, Inc. |
Chimeric amino acid analogues
|
US5650133A
(en)
|
1990-01-19 |
1997-07-22 |
Nycomed Salutar |
Macrocyclic polyaza dichelates linked through ring nitrogens via an amide or ester functionality
|
US5712418A
(en)
|
1989-10-23 |
1998-01-27 |
Research Corporation Technologies, Inc. |
Synthesis and use of amino acid fluorides as peptide coupling reagents
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
US5245009A
(en)
|
1990-03-23 |
1993-09-14 |
The Salk Institute For Biological Studies |
CRF antagonists
|
CA2047042A1
(en)
|
1990-07-19 |
1992-01-20 |
John Hannah |
Cyclic hiv principal neutralizing determinant peptides
|
US5190521A
(en)
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
JPH06501950A
(ja)
|
1990-10-11 |
1994-03-03 |
ベーリンガー インゲルハイム コマンディトゲゼルシャフト |
環状ペプチド、その調製法およびその薬理組成物としての使用
|
EP0488258B1
(de)
|
1990-11-27 |
1996-04-17 |
Fuji Photo Film Co., Ltd. |
Propenamidderivate, deren Polymere, Copolymere und deren Verwendung
|
US5124454A
(en)
|
1990-11-30 |
1992-06-23 |
Minnesota Mining And Manufacturing Company |
Polycyclic diamines and method of preparation
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
CA2103577A1
(en)
|
1991-02-07 |
1992-08-08 |
Michael Kahn |
Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
|
US5747469A
(en)
|
1991-03-06 |
1998-05-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising DNA damaging agents and p53
|
US5364851A
(en)
|
1991-06-14 |
1994-11-15 |
International Synthecon, Llc |
Conformationally restricted biologically active peptides, methods for their production and uses thereof
|
CA2072249C
(en)
|
1991-06-28 |
2003-06-17 |
Saiko Hosokawa |
Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
|
GB9114949D0
(en)
|
1991-07-11 |
1991-08-28 |
Smithkline Beecham Plc |
Novel compounds
|
DE69220861T2
(de)
|
1991-08-13 |
1997-11-20 |
Takeda Chemical Industries Ltd |
Zyklische Peptide und ihre Verwendung
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
US7517644B1
(en)
|
1991-08-23 |
2009-04-14 |
Larry J. Smith |
Method and compositions for cellular reprogramming
|
SE9102652D0
(sv)
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
IL103252A
(en)
|
1991-09-30 |
1997-03-18 |
Du Pont Merck Pharma |
CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
ES2133295T3
(es)
|
1991-11-19 |
1999-09-16 |
Takeda Chemical Industries Ltd |
Peptidos ciclicos y su uso.
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
EP1253156A3
(de)
|
1992-04-03 |
2004-01-07 |
California Institute Of Technology |
Hochwirksame Ruthenium- oder Osmium- Metall-Carben-Komplexe für Olefinmetathesereaktionen, und deren Herstellung und Verwendung
|
US5411860A
(en)
|
1992-04-07 |
1995-05-02 |
The Johns Hopkins University |
Amplification of human MDM2 gene in human tumors
|
ES2139012T3
(es)
|
1992-05-26 |
2000-02-01 |
Univ Leiden |
Peptidos de la proteina p53 humana destinados para ser utilizados en composiciones que inducen una reaccion en los linfocitos t humanos, y linfocitos t citotoxicos especificos de la proteina p53 humana.
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
AU6415894A
(en)
|
1993-03-29 |
1994-10-24 |
Du Pont Merck Pharmaceutical Company, The |
Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia
|
CA2161108A1
(en)
|
1993-04-23 |
1994-11-10 |
Herbert J. Evans |
Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
|
US5446128A
(en)
|
1993-06-18 |
1995-08-29 |
The Board Of Trustees Of The University Of Illinois |
Alpha-helix mimetics and methods relating thereto
|
US5622852A
(en)
|
1994-10-31 |
1997-04-22 |
Washington University |
Bcl-x/Bcl-2 associated cell death regulator
|
US5536814A
(en)
|
1993-09-27 |
1996-07-16 |
La Jolla Cancer Research Foundation |
Integrin-binding peptides
|
JPH09505735A
(ja)
|
1993-11-22 |
1997-06-10 |
オニックス ファーマシューティカルズ,インコーポレイティド |
p53−結合性ポリペプチド及びそれをコードするポリヌクレオチド
|
US6287787B1
(en)
|
1993-11-24 |
2001-09-11 |
Torrey Pines Institute For Molecular Studies |
Dimeric oligopeptide mixture sets
|
AU1967495A
(en)
|
1994-02-18 |
1995-09-04 |
Cell Therapeutics, Inc. |
Intracellular signalling mediators
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
US5824483A
(en)
|
1994-05-18 |
1998-10-20 |
Pence Inc. |
Conformationally-restricted combinatiorial library composition and method
|
IL109943A
(en)
|
1994-06-08 |
2006-08-01 |
Develogen Israel Ltd |
Conformationally constrained backbone cyclized peptide analogs
|
US6407059B1
(en)
|
1994-06-08 |
2002-06-18 |
Peptor Limited |
Conformationally constrained backbone cyclized peptide analogs
|
US5807746A
(en)
|
1994-06-13 |
1998-09-15 |
Vanderbilt University |
Method for importing biologically active molecules into cells
|
US7553929B2
(en)
|
1994-06-13 |
2009-06-30 |
Vanderbilt University |
Cell permeable peptides for inhibition of inflammatory reactions and methods of use
|
US5770377A
(en)
|
1994-07-20 |
1998-06-23 |
University Of Dundee |
Interruption of binding of MDM2 and P53 protein and therapeutic application thereof
|
US5702908A
(en)
|
1994-07-20 |
1997-12-30 |
University Of Dundee |
Interruption of binding of MDM2 and p53 protein and therapeutic application thereof
|
ES2336976T3
(es)
|
1994-09-19 |
2010-04-19 |
Ricardo J. Moro |
Deteccion de cancer.
|
ATE544776T1
(de)
|
1994-12-29 |
2012-02-15 |
Massachusetts Inst Technology |
Chimäre dna-bindeproteine
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
US6169073B1
(en)
|
1995-02-16 |
2001-01-02 |
Bayer Corporation |
Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function
|
EP0729972A1
(de)
|
1995-02-28 |
1996-09-04 |
F. Hoffmann-La Roche Ag |
Tetrahydronaphthalin-Peptidderivate
|
US6514942B1
(en)
|
1995-03-14 |
2003-02-04 |
The Board Of Regents, The University Of Texas System |
Methods and compositions for stimulating T-lymphocytes
|
US5675001A
(en)
|
1995-03-14 |
1997-10-07 |
Hoffman/Barrett, L.L.C. |
Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom
|
US5731408A
(en)
|
1995-04-10 |
1998-03-24 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Peptides having potent antagonist and agonist bioactivities at melanocortin receptors
|
US6054556A
(en)
|
1995-04-10 |
2000-04-25 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Melanocortin receptor antagonists and agonists
|
US5672584A
(en)
|
1995-04-25 |
1997-09-30 |
The University Of Kansas |
Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
|
US6184344B1
(en)
|
1995-05-04 |
2001-02-06 |
The Scripps Research Institute |
Synthesis of proteins by native chemical ligation
|
SI0832096T1
(en)
|
1995-05-04 |
2001-12-31 |
Scripps Research Inst |
Synthesis of proteins by native chemical ligation
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
US5817789A
(en)
|
1995-06-06 |
1998-10-06 |
Transkaryotic Therapies, Inc. |
Chimeric proteins for use in transport of a selected substance into cells
|
US6051554A
(en)
|
1995-06-07 |
2000-04-18 |
Peptor Limited |
Conformationally constrained backbone cyclized somatostatin analogs
|
US5811515A
(en)
|
1995-06-12 |
1998-09-22 |
California Institute Of Technology |
Synthesis of conformationally restricted amino acids, peptides, and peptidomimetics by catalytic ring closing metathesis
|
FR2738151B1
(fr)
|
1995-09-04 |
1997-09-26 |
Rhone Poulenc Rorer Sa |
Antagonistes de l'activite oncogenique de la proteine mdm2, et leur utilisation dans le traitement des cancers
|
GB9521544D0
(en)
|
1995-10-20 |
1995-12-20 |
Univ Dundee |
Activation of P53 protein and therapeutic applications thereof
|
US5840833A
(en)
|
1995-10-27 |
1998-11-24 |
Molecumetics, Ltd |
Alpha-helix mimetics and methods relating thereto
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
EP0880357A4
(de)
|
1996-01-17 |
1999-05-12 |
California Inst Of Techn |
Synthese von konformatorisch eingeschränkten aminosäuren, peptiden und peptidomimetischen verbindungen durch katalytischen ringschluss-metathese
|
US5849954A
(en)
|
1996-01-18 |
1998-12-15 |
Research Corporation Technologies, Inc. |
Method of peptide synthesis
|
US5849691A
(en)
|
1996-02-20 |
1998-12-15 |
The United States Of America As Represented By The Department Of Health And Human Services |
Peptidomimetic inhibitors of cathepsin D and plasmepsins I and II
|
WO1998037090A1
(en)
|
1997-02-20 |
1998-08-27 |
Yeda Research And Development Co. Ltd. |
Antipathogenic synthetic peptides and compositions comprising them
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
JP3792777B2
(ja)
|
1996-05-10 |
2006-07-05 |
株式会社カネカ |
1−アルコキシカルボニル−3−フェニルプロピル誘導体の製造方法
|
US5817752A
(en)
|
1996-06-06 |
1998-10-06 |
La Jolla Pharmaceutical Company |
Cyclic polypeptides comprising a thioether linkage and methods for their preparation
|
US5663316A
(en)
|
1996-06-18 |
1997-09-02 |
Clontech Laboratories, Inc. |
BBC6 gene for regulation of cell death
|
WO1998001467A2
(en)
|
1996-07-05 |
1998-01-15 |
Novartis Ag |
Inhibitors of the interaction between p53 and mdm2
|
US7083983B2
(en)
|
1996-07-05 |
2006-08-01 |
Cancer Research Campaign Technology Limited |
Inhibitors of the interaction between P53 and MDM2
|
US5955593A
(en)
|
1996-09-09 |
1999-09-21 |
Washington University |
BH3 interacting domain death agonist
|
US20020064546A1
(en)
|
1996-09-13 |
2002-05-30 |
J. Milton Harris |
Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
|
US5965703A
(en)
|
1996-09-20 |
1999-10-12 |
Idun Pharmaceuticals |
Human bad polypeptides, encoding nucleic acids and methods of use
|
US5856445A
(en)
|
1996-10-18 |
1999-01-05 |
Washington University |
Serine substituted mutants of BCL-XL /BCL-2 associated cell death regulator
|
WO1998017625A1
(fr)
|
1996-10-22 |
1998-04-30 |
Daiichi Pharmaceutical Co., Ltd. |
Nouveaux remedes pour des maladies infectieuses
|
US6271198B1
(en)
|
1996-11-06 |
2001-08-07 |
Genentech, Inc. |
Constrained helical peptides and methods of making same
|
EP0948343B1
(de)
|
1996-11-21 |
2006-02-08 |
Promega Corporation |
Alkyl peptidamide für topische verwendung
|
CZ290347B6
(cs)
|
1997-02-07 |
2002-07-17 |
Ústav organické chemie a biochemie AV ČR |
Cyklopeptidy stimulující uvolňování růstového hormonu a způsob jejich přípravy
|
US6849428B1
(en)
|
1997-03-05 |
2005-02-01 |
New England Biolabs, Inc. |
Intein-mediated protein ligation of expressed proteins
|
JP2002506423A
(ja)
|
1997-04-11 |
2002-02-26 |
イーライ・リリー・アンド・カンパニー |
ペプチド模倣型大員環のコンビナトリアルライブラリーとそのための方法
|
GB9708092D0
(en)
|
1997-04-22 |
1997-06-11 |
Univ Dundee |
Materials and methods relating to inhibiting the interaction of p53 and mdm2
|
AU7238098A
(en)
|
1997-05-15 |
1998-12-08 |
Kyowa Hakko Kogyo Co. Ltd. |
Peptides having cyclic structures and exerting p53 protein activty-restoring effect on p53 protein mutants
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
JP2001524301A
(ja)
|
1997-09-17 |
2001-12-04 |
ザ・ワルター・アンド・エリザ・ホール・インスティテュート・オヴ・メディカル・リサーチ |
新規治療用分子
|
US6420136B1
(en)
|
1997-09-26 |
2002-07-16 |
University Technologies International, Inc. |
Method of modulating p53 activity
|
US6165732A
(en)
|
1997-10-14 |
2000-12-26 |
Washington University |
Method for identifying apoptosis modulating compounds
|
US6875594B2
(en)
|
1997-11-13 |
2005-04-05 |
The Rockefeller University |
Methods of ligating expressed proteins
|
US6177076B1
(en)
|
1997-12-09 |
2001-01-23 |
Thomas Jefferson University |
Method of treating bladder cancer with wild type vaccinia virus
|
ES2211033T3
(es)
|
1998-01-07 |
2004-07-01 |
Debio Recherche Pharmaceutique S.A. |
Acrilatos de polietilenglicol heterobifuncionales degradables y geles y conjugados derivados de dichos acrilatos.
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
US6030997A
(en)
|
1998-01-21 |
2000-02-29 |
Eilat; Eran |
Acid labile prodrugs
|
AU767185B2
(en)
|
1998-03-23 |
2003-11-06 |
President And Fellows Of Harvard College |
Synthesis of compounds and libraries of compounds
|
CA2325572A1
(en)
|
1998-04-15 |
1999-10-21 |
Aventis Pharmaceuticals Products Inc. |
Process for the preparation of resin-bound cyclic peptides
|
US6288234B1
(en)
|
1998-06-08 |
2001-09-11 |
Advanced Medicine, Inc. |
Multibinding inhibitors of microsomal triglyceride transferase protein
|
US6326354B1
(en)
|
1998-08-19 |
2001-12-04 |
Washington University |
Modulation of apoptosis with bid
|
US7173005B2
(en)
|
1998-09-02 |
2007-02-06 |
Antyra Inc. |
Insulin and IGF-1 receptor agonists and antagonists
|
US6572856B1
(en)
|
1998-09-10 |
2003-06-03 |
The University Of Virginia Patent Foundation |
Methods for the prevention and treatment of cancer using anti-C3b(i) antibodies
|
WO2000044364A2
(en)
|
1999-01-29 |
2000-08-03 |
The Board Of Trustees Of The University Of Illinois |
P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant
|
US6372490B1
(en)
|
1999-02-23 |
2002-04-16 |
Curagen Corporation |
Nucleic acid encoding the MDM interacting protein
|
EP1216309A2
(de)
|
1999-03-01 |
2002-06-26 |
Variagenics, Inc. |
Verfahren zum auffinden von molekülen, die an rns binden
|
ATE393783T1
(de)
|
1999-03-29 |
2008-05-15 |
Procter & Gamble |
Melanocortinrezeptor-liganden
|
US6444425B1
(en)
|
1999-04-02 |
2002-09-03 |
Corixa Corporation |
Compounds for therapy and diagnosis of lung cancer and methods for their use
|
US6713280B1
(en)
|
1999-04-07 |
2004-03-30 |
Thomas Jefferson University |
Enhancement of peptide cellular uptake
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
CA2371922C
(en)
|
1999-05-24 |
2012-03-27 |
Introgen Therapeutics, Inc. |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
|
US6831155B2
(en)
|
1999-12-08 |
2004-12-14 |
President And Fellows Of Harvard College |
Inhibition of p53 degradation
|
US6348558B1
(en)
|
1999-12-10 |
2002-02-19 |
Shearwater Corporation |
Hydrolytically degradable polymers and hydrogels made therefrom
|
EP1243923B1
(de)
|
1999-12-16 |
2006-03-08 |
Chugai Seiyaku Kabushiki Kaisha |
VERFAHREN ZUM AUFFINDEN EINES HEILMITTELS FÜR KREBS MIT HILFE VON INTERAKTIONSDOMÄNEN VON p53 UND MORTALIN
|
DE10009341A1
(de)
|
2000-02-22 |
2001-09-06 |
Florian Kern |
Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
|
US6495674B1
(en)
|
2000-02-25 |
2002-12-17 |
The Salk Institute For Biological Studies |
Evectins and their use
|
US7166712B2
(en)
|
2000-07-12 |
2007-01-23 |
Philadelphia, Health And Education Corporation |
Mammalian MDM2 binding proteins and uses thereof
|
US7049290B2
(en)
|
2000-07-28 |
2006-05-23 |
Universität Zürich |
Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereon
|
US20040228866A1
(en)
|
2000-08-04 |
2004-11-18 |
Ludwig Institute For Cancer Research |
Suppressor genes
|
US6703382B2
(en)
|
2000-08-16 |
2004-03-09 |
Georgetown University Medical Center |
Small molecule inhibitors targeted at Bcl-2
|
HUP0303854A2
(hu)
|
2000-09-08 |
2004-03-01 |
Gryhon Therapeutics, Inc. |
Szintetikus erythropoiesis-stimuláló proteinek
|
EP1343884A2
(de)
|
2000-12-19 |
2003-09-17 |
The Johns Hopkins University |
Durch jfy1 protein induzierte schnelle apoptosis
|
JP4310106B2
(ja)
|
2001-02-23 |
2009-08-05 |
ポリファー リミテッド |
抗菌活性を有するテンプレート結合ペプチド擬似体
|
GB0104588D0
(en)
|
2001-02-24 |
2001-04-11 |
Univ Dundee |
Novel p-53 inducible protein
|
DE10109813A1
(de)
|
2001-03-01 |
2002-09-12 |
Thomas Stanislawski |
Tumor-Peptidantigen aus humanem mdm2 Proto-Onkogen
|
US20050054770A1
(en)
|
2001-03-09 |
2005-03-10 |
Spatola Arno F. |
Helicomimetics and stabilized lxxll peptidomimetics
|
JPWO2003014056A1
(ja)
|
2001-08-08 |
2004-11-25 |
鐘淵化学工業株式会社 |
光学活性2−置換カルボン酸の製造法
|
US20040106548A1
(en)
|
2001-09-07 |
2004-06-03 |
Schmidt Michelle A |
Conformationally constrained labeled peptides for imaging and therapy
|
US20020045192A1
(en)
|
2001-09-19 |
2002-04-18 |
St. Jude Children's Research Hospital |
Arf and HDM2 interaction domains and methods of use thereof
|
CN101157924A
(zh)
|
2001-12-11 |
2008-04-09 |
人体基因组科学有限公司 |
嗜中性白细胞因子α
|
EP1321474A1
(de)
|
2001-12-18 |
2003-06-25 |
Universite De Geneve |
Methode zur Einleitung von Apoptose
|
CA2471719A1
(en)
|
2001-12-31 |
2003-07-17 |
Dana-Farber Cancer Institute, Inc. |
Method of treating apoptosis and compositions thereof
|
IL162604A0
(en)
|
2002-01-03 |
2005-11-20 |
Yissum Res Dev Co |
Conformationally constrained c-backbone cyclic peptides
|
AU2003211093A1
(en)
|
2002-02-15 |
2003-09-09 |
The Regents Of The University Of Michigan |
Inhibitors of rgs proteins
|
US20030166138A1
(en)
|
2002-02-21 |
2003-09-04 |
Todd Kinsella |
Cyclic peptides and analogs useful to treat allergies
|
US7498134B2
(en)
|
2002-03-30 |
2009-03-03 |
The Trustees Of Columbia University In The City Of New York |
HAUSP-Mdm2 interaction and uses thereof
|
RU2004133894A
(ru)
|
2002-04-22 |
2005-04-20 |
Юниверсити Оф Флорида (Us) |
Функционализированные наночастицы и способы их применения
|
US20060189511A1
(en)
|
2002-05-13 |
2006-08-24 |
Koblish Holly K |
Method for cytoprotection through mdm2 and hdm2 inhibition
|
ES2566761T3
(es)
|
2002-05-30 |
2016-04-15 |
The Scripps Research Institute |
Ligación de azidas y acetilenos catalizada por cobre
|
WO2003102538A2
(en)
|
2002-05-30 |
2003-12-11 |
European Molecular Biology Laboratory |
Combinatorial chemical library ii
|
US7208154B2
(en)
|
2002-06-03 |
2007-04-24 |
Regents Of The University Of Michigan |
Methods and compositions for the treatment of MHC-associated conditions
|
SE0201863D0
(en)
|
2002-06-18 |
2002-06-18 |
Cepep Ab |
Cell penetrating peptides
|
AU2003261774A1
(en)
|
2002-09-06 |
2004-03-29 |
Kaneka Corporation |
PROCESS FOR PRODUCING L-Alpha-METHYLCYSTEINE DERIVATIVE
|
AU2003267124A1
(en)
|
2002-09-09 |
2004-03-29 |
Dana-Farber Cancer Institute, Inc. |
Bh3 peptides and method of use thereof
|
AU2003277891A1
(en)
|
2002-09-23 |
2004-04-08 |
Medivir Ab |
Hcv ns-3 serine protease inhibitors
|
CA2487206A1
(en)
|
2002-10-07 |
2004-04-15 |
Ludwig Institute Cancer Research |
P53 binding polypeptide
|
CA2814266A1
(en)
|
2002-10-24 |
2004-05-06 |
Dow Global Technologies Llc |
Stabilization of olefin metathesis product mixtures
|
US20040152708A1
(en)
|
2002-11-07 |
2004-08-05 |
Yong Li |
Trans-9,10-dehydroepothilone C and D, analogs thereof and methods of making the same
|
KR100699614B1
(ko)
|
2002-11-08 |
2007-03-23 |
에프. 호프만-라 로슈 아게 |
퍼옥시좀 증식자 활성화된 수용체 작용제로서의 치환된4-알콕시옥사졸 유도체
|
US20050227932A1
(en)
|
2002-11-13 |
2005-10-13 |
Tianbao Lu |
Combinational therapy involving a small molecule inhibitor of the MDM2: p53 interaction
|
US7166575B2
(en)
|
2002-12-17 |
2007-01-23 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
|
US20070032417A1
(en)
|
2002-12-24 |
2007-02-08 |
Walter And Eliza Hall Institute Of Medical Research |
Peptides and therapeutic uses thereof
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
JPWO2004076483A1
(ja)
|
2003-02-26 |
2006-06-01 |
独立行政法人科学技術振興機構 |
癌細胞のアポトーシスを誘導する転写因子
|
EP1452868A2
(de)
|
2003-02-27 |
2004-09-01 |
Pepscan Systems B.V. |
Verfahren zur Selektion eines potenziellen Arzneimittels
|
US7632920B2
(en)
|
2003-04-10 |
2009-12-15 |
Schering Corporation |
Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof
|
AU2003902743A0
(en)
|
2003-06-02 |
2003-06-19 |
Promics Pty Limited |
Process for the preparation of cyclic peptides
|
WO2005000876A2
(en)
|
2003-06-27 |
2005-01-06 |
Proteologics, Inc. |
Ring finger family proteins and uses related thereto
|
WO2005007675A2
(en)
|
2003-07-09 |
2005-01-27 |
The Scripps Research Institute |
TRIAZOLE ϵ-AMINO ACIDS
|
GB0317815D0
(en)
|
2003-07-30 |
2003-09-03 |
Amersham Health As |
Imaging agents
|
CA2536112A1
(en)
|
2003-08-20 |
2005-03-03 |
Northern Sydney And Central Coast Area Health Service |
Methods for enhancing embryo viability
|
AU2004277981B2
(en)
|
2003-10-03 |
2009-10-01 |
Merck & Co., Inc. |
Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer's disease
|
US20070207947A1
(en)
|
2003-10-16 |
2007-09-06 |
Aplagen Gmbh |
Stabilized Peptides
|
US20070274915A1
(en)
|
2003-10-17 |
2007-11-29 |
Anjana Rao |
Modulation Of Anergy And Methods For isolating Anergy-Modulating Compounds
|
US7273927B2
(en)
|
2003-11-03 |
2007-09-25 |
University Of Massachusetts |
Mdm2 splice variants
|
PL2332968T3
(pl)
|
2003-11-05 |
2017-08-31 |
Dana-Farber Cancer Institute, Inc. |
Stabilizowane alfa-helikalne peptydy i ich zastosowania
|
WO2005074521A2
(en)
|
2004-01-30 |
2005-08-18 |
The Trustees Of Columbia University In The City Of New York |
C-TERMINAL p53 PALINDROMIC PEPTIDE THAT INDUCES APOPTOSIS OF CELLS WITH ABERRANT p53 AND USES THEREOF
|
GB0404731D0
(en)
|
2004-03-03 |
2004-04-07 |
Indp Administrative Inst Nims |
Method and products for the selective degradation of proteins
|
EP1737884B1
(de)
|
2004-03-19 |
2016-10-19 |
The University Of Queensland |
Alpha-helix-mimetika, deren anwendungen und verfahren zu deren herstellung
|
ES2314660T3
(es)
|
2004-05-18 |
2009-03-16 |
F. Hoffmann-La Roche Ag |
Nuevas cis-imidazolinas.
|
WO2005118620A2
(en)
|
2004-05-27 |
2005-12-15 |
New York University |
Methods for preparing internally constraied peptides and peptidomimetics
|
EP1602663A1
(de)
|
2004-06-04 |
2005-12-07 |
Chiralix B.V. |
Glycoaminosäuren und Glycopeptide mit Triazolbindung
|
CN100335467C
(zh)
|
2004-06-04 |
2007-09-05 |
中国科学院上海有机化学研究所 |
一锅法区域选择性合成5-碘代-1,4-二取代-1,2,3-三氮唑化合物
|
US7501397B2
(en)
|
2004-06-04 |
2009-03-10 |
The Brigham And Women's Hospital, Inc. |
Helical peptidomimetics with enhanced activity
|
US7893278B2
(en)
|
2004-06-17 |
2011-02-22 |
Hoffman-La Roche Inc. |
CIS-imidazolines
|
NZ582684A
(en)
|
2004-06-18 |
2011-05-27 |
Ambrx Inc |
Use of an antibody or binding fragment thereof comprising a non naturally encoded amino acid coupled to a linker
|
US7674787B2
(en)
|
2004-07-09 |
2010-03-09 |
The Regents Of The University Of Michigan |
Conformationally constrained Smac mimetics and the uses thereof
|
US9598470B2
(en)
|
2004-10-07 |
2017-03-21 |
Craig W. Beattie |
Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
|
CA2585373A1
(en)
|
2004-10-29 |
2006-05-11 |
Schering Corporation |
Substituted 5-carboxyamide pyrazoles and [1,2,4]triazoles as antiviral agents
|
WO2006069001A2
(en)
|
2004-12-20 |
2006-06-29 |
Baylor College Of Medicine |
Structural requirements for stat3 binding and recruitment to phosphototyrosine ligands
|
GB0428187D0
(en)
|
2004-12-23 |
2005-01-26 |
Univ Liverpool |
Cancer treatment
|
ES2428869T3
(es)
|
2005-01-24 |
2013-11-12 |
Pepscan Systems B.V. |
Compuestos de unión, compuestos inmunógenos y peptidomiméticos
|
FR2881430B1
(fr)
|
2005-02-01 |
2010-10-22 |
Servier Lab |
Nouveaux peptides interagissant avec les membres anti-apoptotiques de la famille de proteines bcl-2 et utilisations
|
SG176463A1
(en)
|
2005-02-22 |
2011-12-29 |
Univ Michigan |
Small molecule inhibitors of mdm2 and uses thereof
|
WO2006103666A2
(en)
|
2005-03-28 |
2006-10-05 |
Yeda Research And Development Co. Ltd. |
Isolated bid polypeptides, polynucleotides encoding same and antibodies directed thereagainst and methods of using same for inducing cell cycle arrest or apoptosis
|
JP5122446B2
(ja)
|
2005-06-13 |
2013-01-16 |
トランザイム・ファーマ,インコーポレイテッド |
大環状グレリン受容体アンタゴニストおよびインバースアゴニストならびにその使用方法
|
CA2618184A1
(en)
*
|
2005-06-17 |
2006-12-28 |
Baxter International Inc. |
Stable buffered, pharmaceutical compositions including motilin-like peptides
|
US20070020620A1
(en)
|
2005-07-14 |
2007-01-25 |
Finn M G |
Compositions and methods for coupling a plurality of compounds to a scaffold
|
JP2009501731A
(ja)
|
2005-07-21 |
2009-01-22 |
ニューサウス イノベーションズ ピティ リミテッド |
癌を治療する方法
|
US20070161544A1
(en)
|
2006-01-06 |
2007-07-12 |
Peter Wipf |
Selective targeting agents for mitcochondria
|
US7538190B2
(en)
|
2006-02-17 |
2009-05-26 |
Polychip Pharmaceuticals Pty Ltd |
Methods for the synthesis of two or more dicarba bridges in organic compounds
|
US7745573B2
(en)
|
2006-02-17 |
2010-06-29 |
Polychip Pharmaceuticals Pty Ltd. |
Conotoxin analogues and methods for synthesis of intramolecular dicarba bridge-containing peptides
|
GB0611405D0
(en)
|
2006-06-09 |
2006-07-19 |
Univ Belfast |
FKBP-L: A novel inhibitor of angiogenesis
|
KR20090042779A
(ko)
|
2006-06-30 |
2009-04-30 |
쉐링 코포레이션 |
P53 활성을 증가시키는 치환된 피페리딘 및 이의 사용
|
CN101511361A
(zh)
|
2006-06-30 |
2009-08-19 |
先灵公司 |
使用增强p53活性的取代哌啶的方法
|
NZ574423A
(en)
|
2006-07-26 |
2012-04-27 |
Pepscan Systems Bv |
Immunogenic compounds and protein mimics
|
US8614192B2
(en)
|
2006-07-28 |
2013-12-24 |
Leiden University Medical Center |
Method for treating ocular cancer
|
US7737174B2
(en)
|
2006-08-30 |
2010-06-15 |
The Regents Of The University Of Michigan |
Indole inhibitors of MDM2 and the uses thereof
|
EP2099445B1
(de)
|
2006-09-04 |
2010-11-17 |
University Court of The University of Dundee |
P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen
|
WO2008033557A2
(en)
|
2006-09-15 |
2008-03-20 |
Siemens Medical Solutions Usa, Inc. |
Click chemistry-derived cyclic peptidomimetics as integrin markers
|
MX2009002735A
(es)
|
2006-09-21 |
2009-05-08 |
Hoffmann La Roche |
Derivados de oxindol como agentes anticancerigenos.
|
US7897394B2
(en)
|
2006-09-21 |
2011-03-01 |
Intrexon Corporation |
Endoplasmic reticulum localization signals
|
WO2008045238A2
(en)
|
2006-10-05 |
2008-04-17 |
New York Blood Center, Inc. |
Stabilized therapeutic small helical antiviral peptides
|
EP2997973A1
(de)
|
2006-11-15 |
2016-03-23 |
Dana-Farber Cancer Institute, Inc. |
Stabilisierte maml-peptide und deren verwendungen
|
US7932397B2
(en)
|
2006-11-22 |
2011-04-26 |
Massachusetts Institute Of Technology |
Olefin metathesis catalysts and related methods
|
CA2686827C
(en)
|
2006-12-14 |
2014-09-16 |
Aileron Therapeutics, Inc. |
Bis-sulfhydryl macrocyclization systems
|
US7981998B2
(en)
|
2006-12-14 |
2011-07-19 |
Aileron Therapeutics, Inc. |
Bis-sulfhydryl macrocyclization systems
|
EP2121007A1
(de)
|
2006-12-21 |
2009-11-25 |
Cytos Biotechnology AG |
Kreisförmige ccr5-peptid-konjugate und ihre verwendung
|
US8633163B2
(en)
|
2007-01-29 |
2014-01-21 |
Polyphor Ltd. |
Template-fixed peptidomimetics
|
CA2677045C
(en)
|
2007-01-31 |
2016-10-18 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
CN101244053B
(zh)
*
|
2007-02-16 |
2010-12-08 |
石药集团中奇制药技术(石家庄)有限公司 |
以多西他赛为主组分的新的分散体系
|
EP3301108A1
(de)
|
2007-02-23 |
2018-04-04 |
Aileron Therapeutics, Inc. |
Makrocyclische systeme von triazol
|
WO2008106507A2
(en)
|
2007-02-27 |
2008-09-04 |
University Of South Florida |
Mdm2/mdmx inhibitor peptide
|
KR101623985B1
(ko)
|
2007-03-28 |
2016-05-25 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
스티칭된 폴리펩티드
|
AU2008247606A1
(en)
|
2007-05-02 |
2008-11-13 |
Dana-Farber Cancer Institute, Inc. |
Methods of modulating cellular homeostatic pathways and cellular survival
|
JP2010530846A
(ja)
*
|
2007-06-01 |
2010-09-16 |
アコロジックス インコーポレイティッド |
高温で安定なペプチド製剤
|
ATE547415T1
(de)
|
2007-09-21 |
2012-03-15 |
Janssen Pharmaceutica Nv |
Inhibitoren der wechselwirkung zwischen mdm2 und p53
|
JP5783721B2
(ja)
|
2007-09-26 |
2015-09-24 |
ダナ ファーバー キャンサー インスティテュート インコーポレイテッド |
Bcl−2ファミリーポリペプチドを調節する方法及び組成物
|
JP5653219B2
(ja)
|
2007-12-31 |
2015-01-14 |
ニューヨーク ユニバーシティ |
水素結合サロゲートをベースとする人工ヘリックスによるウイルス宿主膜融合の制御
|
EP2235064B1
(de)
|
2008-01-07 |
2015-11-25 |
Amgen Inc. |
Verfahren zur herstellung von fc-heterodimeren antikörpermolekülen anhand elektrostatischer steuereffekte
|
EP2242578B1
(de)
|
2008-01-25 |
2017-11-01 |
Trustees of Boston College |
Katalysatoren für metathesereaktionen einschliesslich enantioselektiver olefinmetathese
|
CA2713232C
(en)
|
2008-01-25 |
2020-05-05 |
P53, Inc. |
P53 biomarkers
|
US20090275519A1
(en)
|
2008-02-08 |
2009-11-05 |
Aileron Therapeutics, Inc. |
Therapeutic peptidomimetic macrocycles
|
US20110144303A1
(en)
|
2008-04-08 |
2011-06-16 |
Aileron Therapeutics, Inc. |
Biologically Active Peptidomimetic Macrocycles
|
WO2009126292A2
(en)
|
2008-04-08 |
2009-10-15 |
Aileron Therapeutics, Inc. |
Biologically active peptidomimetic macrocycles
|
EP2283033A1
(de)
|
2008-05-06 |
2011-02-16 |
New York Blood Center |
Antivirale zellenpenetrierende peptide
|
US20110250685A1
(en)
|
2008-06-03 |
2011-10-13 |
Nash Huw M |
Compositions and methods for enhancing cellular transport of biomolecules
|
WO2009149339A2
(en)
|
2008-06-05 |
2009-12-10 |
University Of Maryland, Baltimore |
P53 activator peptides
|
WO2010011313A2
(en)
|
2008-07-23 |
2010-01-28 |
President And Fellows Of Harvard College |
Ligation of stapled polypeptides
|
GB0813873D0
(en)
|
2008-07-30 |
2008-09-03 |
Univ Dundee |
Compounds
|
GB2467691A
(en)
|
2008-09-05 |
2010-08-11 |
Aueon Inc |
Methods for stratifying and annotating cancer drug treatment options
|
WO2010033617A2
(en)
|
2008-09-16 |
2010-03-25 |
The Research Foundation Of State University Of New York |
Stapled peptides and method of synthesis
|
EP2344520B1
(de)
|
2008-09-18 |
2013-11-13 |
New York University |
Hemmung der interaktion zwischen hif-1a und p300/cbp mit helices auf wasserstoffbrückensurrogatbasis
|
JP2012503024A
(ja)
|
2008-09-22 |
2012-02-02 |
エルロン・セラピューティクス・インコーポレイテッド |
ペプチド模倣大環状分子
|
US20120115793A1
(en)
|
2008-09-22 |
2012-05-10 |
Alleron therapeutics, Inc |
Peptidomimetic macrocycles
|
WO2010034031A1
(en)
*
|
2008-09-22 |
2010-03-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
CN104961795A
(zh)
|
2008-09-22 |
2015-10-07 |
爱勒让治疗公司 |
用于制备纯化的多肽组合物的方法
|
BRPI0918948A2
(pt)
|
2008-09-22 |
2015-12-15 |
Aileron Therapeutics Inc |
macrociclos peptidomiméticos
|
EP2329015A1
(de)
|
2008-09-22 |
2011-06-08 |
Aileron Therapeutics, Inc. |
Peptidomimetische makrocyclen
|
EP2338056B1
(de)
|
2008-10-10 |
2018-01-03 |
Dana Farber Cancer Institute |
Chemische modulatoren pro-apoptotischer bax- und bcl-2 polypeptide
|
JP2010120881A
(ja)
|
2008-11-19 |
2010-06-03 |
Keio Gijuku |
ヒト癌タンパク質MDM2とヒト癌抑制タンパク質p53との相互作用阻害ペプチド及びその使用
|
KR101298168B1
(ko)
|
2008-11-21 |
2013-08-20 |
충남대학교산학협력단 |
스네일―p53 간의 결합을 저해하는 화합물 및 이를 유효성분으로 함유하는 암질환 치료제
|
CN102223891A
(zh)
|
2008-11-24 |
2011-10-19 |
爱勒让治疗公司 |
具有改善性质的拟肽大环化合物
|
EP3124494B1
(de)
|
2008-12-09 |
2019-06-19 |
Dana-Farber Cancer Institute, Inc. |
Verfahren und zusammensetzungen zur spezifischen modulation von mcl-1
|
CA2744088A1
(en)
|
2009-01-14 |
2010-07-22 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
WO2010083501A2
(en)
|
2009-01-16 |
2010-07-22 |
University Of South Florida |
Alpha-helix mimetic using a 2,5-oligopyrimidine scaffold
|
US8217051B2
(en)
|
2009-02-17 |
2012-07-10 |
Hoffmann-La Roche Inc. |
Spiroindolinone derivatives
|
FR2942798B1
(fr)
|
2009-03-05 |
2011-04-08 |
Centre Nat Rech Scient |
Peptides utilisables pour le traitement de la leucemie lymphoide chronique
|
US20120135089A1
(en)
|
2009-03-17 |
2012-05-31 |
Stockwell Brent R |
E3 ligase inhibitors
|
US8076482B2
(en)
|
2009-04-23 |
2011-12-13 |
Hoffmann-La Roche Inc. |
3,3′-spiroindolinone derivatives
|
WO2011005219A1
(en)
|
2009-07-07 |
2011-01-13 |
Agency For Science, Technology And Research |
Novel mdm2 binding peptides and uses thereof
|
US9163330B2
(en)
|
2009-07-13 |
2015-10-20 |
President And Fellows Of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
JP2013503129A
(ja)
|
2009-08-26 |
2013-01-31 |
ノバルティス アーゲー |
テトラ−置換ヘテロアリール化合物ならびにmdm2および/またはmdm4モジュレーターとしてのそれらの使用
|
JP2013505300A
(ja)
*
|
2009-09-22 |
2013-02-14 |
エルロン・セラピューティクス・インコーポレイテッド |
ペプチド模倣大環状分子
|
US8017607B2
(en)
|
2009-10-14 |
2011-09-13 |
Hoffmann-La Roche Inc. |
N-substituted-pyrrolidines as inhibitors of MDM2-P-53 interactions
|
WO2011047215A1
(en)
|
2009-10-14 |
2011-04-21 |
Aileron Therapeutics, Inc. |
Improved peptidomimetic macrocycles
|
WO2011056961A2
(en)
|
2009-11-04 |
2011-05-12 |
Health Research Inc. |
Method and compositions for suppression of aging
|
KR20120099462A
(ko)
|
2009-11-12 |
2012-09-10 |
더 리젠츠 오브 더 유니버시티 오브 미시건 |
스피로-옥신돌 mdm2 길항제
|
US20110118283A1
(en)
|
2009-11-17 |
2011-05-19 |
Qingjie Ding |
Substituted Pyrrolidine-2-Carboxamides
|
US8088815B2
(en)
|
2009-12-02 |
2012-01-03 |
Hoffman-La Roche Inc. |
Spiroindolinone pyrrolidines
|
CU24130B1
(es)
|
2009-12-22 |
2015-09-29 |
Novartis Ag |
Isoquinolinonas y quinazolinonas sustituidas
|
US8440693B2
(en)
|
2009-12-22 |
2013-05-14 |
Novartis Ag |
Substituted isoquinolinones and quinazolinones
|
US8658170B2
(en)
|
2010-01-06 |
2014-02-25 |
Joseph P. Errico |
Combination therapy with MDM2 and EFGR inhibitors
|
KR101220516B1
(ko)
|
2010-01-21 |
2013-01-10 |
연세대학교 산학협력단 |
항-mdm2를 발현하는 인간 성체줄기세포 및 그의 용도
|
WO2011097642A1
(en)
|
2010-02-08 |
2011-08-11 |
Trustees Of Boston College |
Efficient methods for z- or cis-selective cross-metathesis
|
US8288431B2
(en)
|
2010-02-17 |
2012-10-16 |
Hoffmann-La Roche Inc. |
Substituted spiroindolinones
|
WO2011106650A2
(en)
|
2010-02-27 |
2011-09-01 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Novel p53-mdm2/p53-mdm4 antagonists to treat proliferative disease
|
CA2800519A1
(en)
|
2010-04-09 |
2011-10-13 |
The Regents Of The University Of Michigan |
Biomarkers for mdm2 inhibitors for use in treating disease
|
US20130177979A1
(en)
|
2010-06-22 |
2013-07-11 |
University Of Central Florida Research Foundation, Inc. |
Methods and compositions for cell permeable stat3 inhibitor
|
US20110313167A1
(en)
|
2010-06-22 |
2011-12-22 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Substituted Heterocycles as Therapeutic agents for treating cancer
|
US8907053B2
(en)
|
2010-06-25 |
2014-12-09 |
Aurigene Discovery Technologies Limited |
Immunosuppression modulating compounds
|
US8975232B2
(en)
|
2010-07-29 |
2015-03-10 |
President And Fellows Of Harvard College |
Macrocyclic kinase inhibitors and uses thereof
|
CA2807685C
(en)
|
2010-08-13 |
2020-10-06 |
Aileron Therapeutics, Inc. |
P53 derived peptidomimetic macrocycle
|
WO2012033525A2
(en)
|
2010-09-08 |
2012-03-15 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
P53-mdm2 antagonists
|
US20120065210A1
(en)
|
2010-09-15 |
2012-03-15 |
Xin-Jie Chu |
Substituted hexahydropyrrolo[1,2-c]imidazolones
|
US20120071499A1
(en)
|
2010-09-20 |
2012-03-22 |
Xin-Jie Chu |
Substituted Spiro[3H-Indole-3,6'(5'H)-[1H]Pyrrolo[1,2c]Imidazole-1',2(1H,2'H)-diones
|
WO2012040459A2
(en)
|
2010-09-22 |
2012-03-29 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
US20130225603A1
(en)
|
2010-09-27 |
2013-08-29 |
Serrata Llc |
Mdm2 inhibitors for treatment of ocular conditions
|
ES2685175T3
(es)
|
2010-09-30 |
2018-10-05 |
St. Jude Children's Research Hospital |
Imidazoles sustituidos con arilo
|
US9169295B2
(en)
|
2010-10-13 |
2015-10-27 |
Bristol-Myers Squibb Company |
Macrocycles and macrocycle stabilized peptides
|
FR2967072B1
(fr)
|
2010-11-05 |
2013-03-29 |
Univ Dundee |
Procede pour ameliorer la production de virus et semences vaccinales influenza
|
EP2638046A4
(de)
|
2010-11-12 |
2014-06-25 |
Univ Michigan |
Spiro-oxindol-mdm2-antagonisten
|
US10822374B2
(en)
|
2010-11-12 |
2020-11-03 |
Dana-Farber Cancer Institute, Inc. |
Cancer therapies and diagnostics
|
WO2012076513A1
(en)
|
2010-12-09 |
2012-06-14 |
F. Hoffmann-La Roche Ag |
3-cyano-1-hydroxymethyl-2-phenylpyrrolidine derivatives as inhibitors of mdm2-p53 interactions useful for the treatment of cancer
|
EP2651964B1
(de)
|
2010-12-15 |
2018-02-28 |
The Research Foundation of State University of New York |
Vernetzte peptide und proteine, verfahren zu ihrer herstellung und verwendungen davon
|
KR20130088170A
(ko)
|
2010-12-16 |
2013-08-07 |
로슈 글리카트 아게 |
비푸코실화 cd20 항체와 mdm2 저해제와의 조합 치료
|
WO2012083181A1
(en)
|
2010-12-16 |
2012-06-21 |
Indiana University Research And Technology Corporation |
Alpha helix mimetics and methods for using
|
BR112013014986A2
(pt)
|
2010-12-17 |
2016-07-12 |
Syngenta Participations Ag |
compostos inseticidas
|
EP2474624B1
(de)
|
2011-01-05 |
2016-08-17 |
Daniela Kandioler |
Reaktionsvorhersage bei der Krebsbehandlung (p53-adaptierte Krebstherapie)
|
EP2474625B1
(de)
|
2011-01-05 |
2016-11-02 |
Daniela Kandioler |
Verfahren zur Bestimmung des p53-Status in Tumoren
|
JP5950587B2
(ja)
|
2011-02-28 |
2016-07-13 |
キヤノン株式会社 |
多孔質ガラスの製造方法および光学部材の製造方法
|
ES2586411T3
(es)
|
2011-03-04 |
2016-10-14 |
New York University |
Macrociclos sustitutos de enlace de hidrógeno como moduladores de Ras
|
CN103415530A
(zh)
|
2011-03-09 |
2013-11-27 |
Jitsubo株式会社 |
新型的含有非肽性交联结构的交联肽、以及该交联肽的合成方法和用于该方法的新型有机化合物
|
TWI494312B
(zh)
|
2011-03-10 |
2015-08-01 |
Daiichi Sankyo Co Ltd |
二螺吡咯啶衍生物
|
CA2834657A1
(en)
|
2011-04-29 |
2012-11-01 |
Kinemed, Inc. |
Chemical modification of apolipoprotein mimetic peptides for the production of therapeutic agents
|
WO2012173846A2
(en)
|
2011-06-06 |
2012-12-20 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
US9487562B2
(en)
|
2011-06-17 |
2016-11-08 |
President And Fellows Of Harvard College |
Stabilized polypeptides as regulators of RAB GTPase function
|
US20140256912A1
(en)
|
2011-06-17 |
2014-09-11 |
President And Fellows Of Harvard College |
Stabilized Variant MAML Peptides and Uses Thereof
|
GB201110390D0
(en)
|
2011-06-20 |
2011-08-03 |
Medical Res Council |
Compounds for use in stabilising p53 mutants
|
US20120328692A1
(en)
|
2011-06-24 |
2012-12-27 |
University Of Maryland, Baltimore |
Potent d-peptide antagonists of mdm2 and mdmx for anticancer therapy
|
US20130123196A1
(en)
|
2011-08-31 |
2013-05-16 |
New York University |
Thioether-, ether-, and alkylamine-linked hydrogen bond surrogate peptidomimetics
|
US9517252B2
(en)
|
2011-09-09 |
2016-12-13 |
Agency For Science, Technology And Research |
p53 activating peptides
|
EP2760845B1
(de)
|
2011-09-27 |
2016-11-16 |
Amgen Inc. |
Heterocyclische verbindungen als mdm2-hemmer zur behandlung von krebs
|
WO2013059530A2
(en)
|
2011-10-18 |
2013-04-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
JP6342808B2
(ja)
|
2011-10-18 |
2018-06-13 |
エイルロン セラピューティクス,インコーポレイテッド |
ペプチドミメティック大環状化合物
|
EP2771008A4
(de)
|
2011-10-28 |
2015-04-08 |
Merck Sharp & Dohme |
Makrozyklen zur erhöhung einer p53-aktivität und verwendungen davon
|
US9408885B2
(en)
|
2011-12-01 |
2016-08-09 |
Vib Vzw |
Combinations of therapeutic agents for treating melanoma
|
CA2761253A1
(en)
|
2011-12-07 |
2013-06-07 |
Vib Vzw |
Combinations of therapeutic agents for treating melanoma
|
CN107216380A
(zh)
|
2012-02-15 |
2017-09-29 |
爱勒让治疗公司 |
拟肽大环化合物
|
AU2013221433B2
(en)
|
2012-02-15 |
2018-01-18 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
US9890429B2
(en)
|
2012-02-29 |
2018-02-13 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits, and methods for the identification, assessment, prevention, and therapy of cancer
|
EP2820041B1
(de)
|
2012-03-02 |
2017-06-14 |
Ludwig Institute For Cancer Research Ltd. |
Iaspp-phosphorylierung und metastatisches potenzial
|
WO2013133405A1
(ja)
*
|
2012-03-09 |
2013-09-12 |
オンコセラピー・サイエンス株式会社 |
ペプチドを含む医薬組成物
|
US9216170B2
(en)
|
2012-03-19 |
2015-12-22 |
Hoffmann-La Roche Inc. |
Combination therapy for proliferative disorders
|
DK2880447T3
(da)
|
2012-07-31 |
2019-08-12 |
Novartis Ag |
Markører forbundet med følsomhed for hæmmere af human double minute 2 (MDM2)
|
HUE054444T2
(hu)
|
2012-09-26 |
2021-09-28 |
Harvard College |
Prolinnal lezárt kapcsos peptidek és felhasználásuk
|
WO2014055564A1
(en)
|
2012-10-01 |
2014-04-10 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
CA2887285A1
(en)
|
2012-11-01 |
2014-05-08 |
Aileron Therapeutics, Inc. |
Disubstituted amino acids and methods of preparation and use thereof
|
WO2014138429A2
(en)
|
2013-03-06 |
2014-09-12 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and use thereof in regulating hif1alpha
|
KR20150131244A
(ko)
|
2013-03-13 |
2015-11-24 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
스테이플드 및 스티치드 폴리펩티드 및 그의 용도
|
WO2014144121A2
(en)
|
2013-03-15 |
2014-09-18 |
Life Technologies Corporation |
Classification and actionability indices for lung cancer
|
US9198910B2
(en)
|
2013-04-04 |
2015-12-01 |
The Translational Genomics Research Institute |
Methods for the treatment of cancer
|
WO2014172479A1
(en)
|
2013-04-16 |
2014-10-23 |
Memorial Sloan-Kettering Cancer Center |
Companion diagnostic for cdk4 inhibitors
|
JP2016523241A
(ja)
|
2013-06-14 |
2016-08-08 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
安定化されたポリペプチドインスリン受容体調節剤
|
JP6461126B2
(ja)
|
2013-07-03 |
2019-01-30 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
Mdm2アンタゴニストを用いた患者のがん治療法をパーソナライズするためのmrnaベースの遺伝子発現
|
US9268662B2
(en)
|
2013-08-01 |
2016-02-23 |
Oracle International Corporation |
Method and system for a high availability framework
|
CA2919837A1
(en)
|
2013-08-02 |
2015-02-05 |
Children's Hospital Medical Center |
Compositions and methods for treating disease states associated with activated t cells and/or b cells
|
WO2015051030A2
(en)
|
2013-10-01 |
2015-04-09 |
President And Fellows Of Harvard College |
Stabilized polypeptides and uses thereof
|
US20160115556A1
(en)
|
2013-10-19 |
2016-04-28 |
Trovagene, Inc. |
Detecting mutations in disease over time
|
PT3068393T
(pt)
|
2013-11-11 |
2022-06-14 |
Amgen Inc |
Terapia de combinação, incluindo um inibidor de mdm2 e um ou mais agentes farmaceuticamente ativos adicionais para o tratamento de cancros
|
JP6297695B2
(ja)
|
2013-12-05 |
2018-03-20 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
急性骨髄性白血病(aml)のための新規併用治療
|
CN105848682A
(zh)
|
2013-12-23 |
2016-08-10 |
诺华股份有限公司 |
药物组合
|
US20160333419A1
(en)
|
2014-01-14 |
2016-11-17 |
Daiichi Sankyo Company, Limited |
Gene signatures associated with sensitivity to mdm2 inhibitors
|
US20170037086A1
(en)
|
2014-04-09 |
2017-02-09 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles with pth activity
|
WO2015179799A1
(en)
|
2014-05-22 |
2015-11-26 |
The General Hospital Corporation |
DD1alpha RECEPTOR AND USES THEREOF IN IMMUNE DISORDERS
|
TW201613576A
(en)
|
2014-06-26 |
2016-04-16 |
Novartis Ag |
Intermittent dosing of MDM2 inhibitor
|
US11344620B2
(en)
|
2014-09-13 |
2022-05-31 |
Novartis Ag |
Combination therapies
|
SG11201702175YA
(en)
|
2014-09-24 |
2017-04-27 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles and formulations thereof
|
CN112245565A
(zh)
|
2014-09-24 |
2021-01-22 |
艾瑞朗医疗公司 |
拟肽大环化合物及其用途
|
JP2017532959A
(ja)
|
2014-10-09 |
2017-11-09 |
第一三共株式会社 |
Mdm2阻害剤に対する感受性の遺伝子シグネチャーに基づく予測因子に関するアルゴリズム
|
US20170227544A1
(en)
|
2014-10-10 |
2017-08-10 |
Hoffmann-La Roche Inc. |
Methods for personalizing patient cancer therapy with an mdm2 antagonist
|
US10302644B2
(en)
|
2014-11-04 |
2019-05-28 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating multiple myeloma
|
EP3237638B1
(de)
|
2014-12-24 |
2020-01-15 |
F.Hoffmann-La Roche Ag |
Therapeutisches, diagnostisches und prognostisches verfahren für blasenkrebs
|
MX2017011834A
(es)
|
2015-03-20 |
2018-04-11 |
Aileron Therapeutics Inc |
Macrociclos peptidomimeticos y usos de los mismos.
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
KR20180022971A
(ko)
|
2015-07-02 |
2018-03-06 |
다나-파버 캔서 인스티튜트 인크. |
안정화된 항미생물성 펩티드
|
WO2017023933A2
(en)
|
2015-08-03 |
2017-02-09 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
EP3344275B8
(de)
|
2015-09-03 |
2023-04-12 |
Aileron Therapeutics, Inc. |
Peptidomimetische makrozyklen und verwendungen davon
|
US10023613B2
(en)
|
2015-09-10 |
2018-07-17 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles as modulators of MCL-1
|
WO2017205786A1
(en)
|
2016-05-27 |
2017-11-30 |
Aileron Therapeutics, Inc. |
Cell permeable peptidomimetic macrocycles
|
WO2017218949A2
(en)
|
2016-06-17 |
2017-12-21 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
WO2018165575A2
(en)
|
2017-03-09 |
2018-09-13 |
Aileron Therapeutics, Inc. |
Warhead-containing peptidomimetic macrocycles as modulators of bfl-1
|